Brief: Egetis Therapeutics Chairman Thomas Lönngren To Decline Re-Election
April 24 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* CHAIRMAN OF BOARD THOMAS LÖNNGREN WISHES TO DECLINE
RE-ELECTION
AS CHAIRMAN
* LÖNNGREN IS AVAILABLE FOR ELECTION AS BOARD MEMBER
* MATS BLOM IS PROPOSED AS NEW CHAIRMAN
Source text for Eikon: ID:nMFN1rcm23
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))